Loading...

PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC Investments/Divestments 8-K Filing

PCFC

PCB

PACIFIC BIOSCIENCES OF CALIFORNIA INC

(PACB)

2023 8-K

Management Changes

Board Appointment

Financial Results Announced

Management Changes

Asset Sale Completed

Financial Results Update

Third Quarter Results

Financial Statements

Financial Statements

Workforce Reductions

Management Change

Lease Amendment

Financial Results

Management Changes

Financial Update

Executive Changes

Management Change

Management Change

Management Change

Financial Results

Debt Exchange Agreement

Expense Reduction Plan

Financial Results Announcement

Equity Incentive Plan Amend...

Financial Results Announcement

Financial Update

Financial Results Announcement

Financial Results Announcement

Resignation of Director

Financial Results Announcement

Appointment of Director and...

Appointment of Director

Financial Results and Acqui...

Exchange of Convertible Sen...

Agreement and Exchange Tran...

Annual Meeting Voting Results

Financial Results Announcement

Financial Results Announcement

Agreement for Stock Offering

Financial Update

External Links:

Pacific Biosciences of California, Inc. entered into a letter agreement with Chimera Investment LLC regarding the conversion of New Notes and lock-up restrictions, and also announced a privately negotiated exchange agreement with Chimera for the issuance of $441 million aggregate principal amount of the Company's 1.375% Convertible Senior Notes due 2030 in exchange for $441 million aggregate principal amount of the Company's 1.50% Convertible Senior Notes due 2028.

AI Assistant

PACIFIC BIOSCIENCES OF CALIFORNIA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.